Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Stimulant-like action of nicotine on striatal dopamine transporter in the brain of adults with attention deficit hyperactivity disorder.

Krause KH, Dresel SH, Krause J, Kung HF, Tatsch K, Ackenheil M.

Int J Neuropsychopharmacol. 2002 Jun;5(2):111-3.

PMID:
12135534
2.

The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder.

Krause KH, Dresel SH, Krause J, la Fougere C, Ackenheil M.

Neurosci Biobehav Rev. 2003 Nov;27(7):605-13. Review.

PMID:
14624805
3.

SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder.

Krause J.

Expert Rev Neurother. 2008 Apr;8(4):611-25. doi: 10.1586/14737175.8.4.611. Review.

PMID:
18416663
4.

ADHD in adolescence and adulthood, with a special focus on the dopamine transporter and nicotine.

Krause J, Krause KH, Dresel SH, la Fougere C, Ackenheil M.

Dialogues Clin Neurosci. 2006;8(1):29-36. Review.

5.

The dopamine transporter and attention-deficit/hyperactivity disorder.

Madras BK, Miller GM, Fischman AJ.

Biol Psychiatry. 2005 Jun 1;57(11):1397-409. Epub 2005 Jan 5. Review.

PMID:
15950014
6.

In vivo neuroreceptor imaging in attention-deficit/hyperactivity disorder: a focus on the dopamine transporter.

Spencer TJ, Biederman J, Madras BK, Faraone SV, Dougherty DD, Bonab AA, Fischman AJ.

Biol Psychiatry. 2005 Jun 1;57(11):1293-300. Review.

PMID:
15950001
7.
8.
9.

The dopamine transporter: role in neurotoxicity and human disease.

Bannon MJ.

Toxicol Appl Pharmacol. 2005 May 1;204(3):355-60. Review.

PMID:
15845424
10.

Genetics of adult attention-deficit/hyperactivity disorder.

Faraone SV.

Psychiatr Clin North Am. 2004 Jun;27(2):303-21. Review.

PMID:
15063999
11.

Pharmacokinetic and pharmacodynamic properties of stimulants: implications for the design of new treatments for ADHD.

Swanson JM, Volkow ND.

Behav Brain Res. 2002 Mar 10;130(1-2):73-8. Review.

PMID:
11864720
12.

Genes and attention deficit hyperactivity disorder.

Swanson J, Posner M, Fusella J, Wasdell M, Sommer T, Fan J.

Curr Psychiatry Rep. 2001 Apr;3(2):92-100. Review.

PMID:
11276403
13.

The dopamine transporter: relevance to attention deficit hyperactivity disorder (ADHD).

Madras BK, Miller GM, Fischman AJ.

Behav Brain Res. 2002 Mar 10;130(1-2):57-63. Review.

PMID:
11864718
14.

Current concepts on the neurobiology of Attention-Deficit/Hyperactivity Disorder.

Biederman J, Faraone SV.

J Atten Disord. 2002;6 Suppl 1:S7-16. Review.

PMID:
12685515
15.

Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis.

Swanson JM, Kinsbourne M, Nigg J, Lanphear B, Stefanatos GA, Volkow N, Taylor E, Casey BJ, Castellanos FX, Wadhwa PD.

Neuropsychol Rev. 2007 Mar;17(1):39-59. Review.

PMID:
17318414
16.

Attention deficit and hyperactivity disorder: review of genetic association studies.

Galili-Weisstub E, Segman RH.

Isr J Psychiatry Relat Sci. 2003;40(1):57-66. Review.

PMID:
12817670
17.

The dopaminergic system in attention deficit/hyperactivity disorder.

Ohno M.

Congenit Anom (Kyoto). 2003 Jun;43(2):114-22. Review.

PMID:
12893970
18.

ADHD, altered dopamine neurotransmission, and disrupted reinforcement processes: implications for smoking and nicotine dependence.

Kollins SH, Adcock RA.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jul 3;52:70-8. doi: 10.1016/j.pnpbp.2014.02.002. Epub 2014 Feb 18. Review.

19.

Neuron membrane trafficking and protein kinases involved in autism and ADHD.

Kitagishi Y, Minami A, Nakanishi A, Ogura Y, Matsuda S.

Int J Mol Sci. 2015 Jan 30;16(2):3095-115. doi: 10.3390/ijms16023095. Review.

Supplemental Content

Support Center